Filtered By:
Source: ESC Heart Failure
Drug: Canagliflozin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program
ConclusionsParticipants on baseline diuretics derived a greater benefit for major cardiovascular events from canagliflozin, which was not fully explained by differences in participant characteristics nor risk factor changes.
Source: ESC Heart Failure - February 17, 2021 Category: Cardiology Authors: Jie Yu,
Clare Arnott,
Brendon L. Neuen,
Hiddo L. Heersprink,
Kenneth W. Mahaffey,
Christopher P. Cannon,
Sadiya S. Khan,
Abigail S. Baldridge,
Sanjiv J. Shah,
Yuli Huang,
Chao Li,
Gemma A. Figtree,
Vlado Perkovic,
Meg J. Jardine,
Bruce Neal, Tags: Original Research Article Source Type: research
